Showing results (481-490 of 2,229) with videos related to

Sort By:
Pageof 223
Cancer Biotherapy & Radiopharmaceuticals|August 17, 2021
circRNA RPPH1 Facilitates the Aggravation of Breast Cancer Development by Regulating miR-542-3p/ARHGAP1 PathwayLiqiang Qi, Bo Sun, Beibei Yang, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 12, 2020
Metformin Affects Paclitaxel Sensitivity of Ovarian Cancer Cells Through Autophagy Mediated by Long Noncoding RNASNHG7/miR-3127-5p AxisZe Yu, Yuezhen Wang, Bin Wang, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 27, 2025
Avatar: Personalized Precision Radio-Genomic Theranostic OncologyJ Harvey Turner
Cancer Biotherapy & Radiopharmaceuticals|February 6, 2026
Clinical Efficacy of Capecitabine and Docetaxel Efficacy in Advanced Triple-Negative Breast Cancer Along with Ultrasound-Mediated Drug DeliveryDongbo Liu, Yujing Liu, Zhangyu Wang, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 29, 2025
Dosimetry Assessment in Predicting Treatment Outcomes Following Yttrium-90 Transarterial Radioembolization of Hepatic TumorsChristina Ward, Sandon Scott, William Wesson, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 20, 2025
Intuitive Human-Artificial Intelligence Theranostic ComplementarityJ Harvey Turner
Cancer Biotherapy & Radiopharmaceuticals|January 2, 2025
Generalized Seizure as an Acute post-[177Lu]Lu-DOTATATE Side Effect in a Case of Recurrent MeningiomaAbdolmajid Alipour, Tahereh Ghaedian, Abbas Rakhsha, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 28, 2025
Microbial Cytotoxic Effect of 212Pb in RadiopharmaceuticalsAaron T Schatzmann, Tania A Stallons, Rachel Rivera, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 4, 2024
Baseline 18F-FDG PET Radiomics Predicting Therapeutic Efficacy of Diffuse Large B-Cell Lymphoma after R-CHOP (-Like) TherapyFenglian Jing, Xinchao Zhang, Yunuan Liu, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 26, 2023
The Prognostic Role of [18F]FDG PET/CT in Patients with Advanced Cutaneous Squamous Cell Carcinoma Submitted to Cemiplimab Immunotherapy: A Single-Center Retrospective StudyLuca Filippi, Ilaria Proietti, Vincenzo Petrozza, et al.
Pageof 223